CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-23 | Hunkapiller Michael Director | Sale | −113,308 | $35.10 | $4.0M | 995,086 |
| 2021-02-23 | Hunkapiller Michael Director | Sale | −74,119 | $35.99 | $2.7M | 920,967 |
| 2021-02-23 | Hunkapiller Michael Director | Sale | −72,562 | $36.85 | $2.7M | 848,405 |
| 2021-02-23 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −86,084 | 35,727 | ||
| 2021-02-23 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −86,065 | 268,045 | ||
| 2021-02-23 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −86,022 | 268,011 | ||
| 2021-02-23 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −86,047 | 268,267 | ||
| 2021-02-23 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −29,103 | 25,002 | ||
| 2021-02-22 | Hunkapiller Michael Director | Option exercise | +45,689 | $6.14 | $281K | 894,094 |
| 2021-02-22 | Hunkapiller Michael Director | Option exercise | +45,890 | $5.72 | $262K | 939,984 |
| 2021-02-22 | Hunkapiller Michael Director | Option exercise | +45,967 | $7.87 | $362K | 985,951 |
| 2021-02-22 | Hunkapiller Michael Director | Option exercise | +45,686 | $5.27 | $241K | 1,031,637 |
| 2021-02-22 | Hunkapiller Michael Director | Option exercise | +45,895 | $2.63 | $121K | 1,077,532 |
| 2021-02-22 | Hunkapiller Michael Director | Sale | −57,260 | $37.17 | $2.1M | 1,020,272 |
| 2021-02-22 | Hunkapiller Michael Director | Sale | −33,491 | $38.08 | $1.3M | 986,781 |
| 2021-02-22 | Hunkapiller Michael Director | Sale | −38,360 | $39.15 | $1.5M | 948,421 |
| 2021-02-22 | Hunkapiller Michael Director | Sale | −57,902 | $40.28 | $2.3M | 890,519 |
| 2021-02-22 | Hunkapiller Michael Director | Sale | −42,114 | $41.06 | $1.7M | 848,405 |
| 2021-02-22 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −45,689 | 121,811 | ||
| 2021-02-22 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −45,890 | 354,110 |
Page 13 of 29 · 561 trades